No Data
No Data
Teladoc Health (NYSE:TDOC Shareholders Incur Further Losses as Stock Declines 5.5% This Week, Taking Three-year Losses to 88%
AI Healthcare Innovations: How They're Shaping the Future for Patients and Investors
BofA Securities Maintains Teladoc Health(TDOC.US) With Hold Rating
Teladoc Health, Inc. (TDOC): A Bull Case Theory
Out-of-consensus Buy Ideas According to Goldman: CAG, TRIP, TDOC
Piper Sandler Maintains Teladoc Health(TDOC.US) With Buy Rating, Raises Target Price to $13